During the past decade, Southeast Houston Research, Inc. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Southeast Houston Research, Inc." are "Attention Deficit Hyperactivity Disorder" (2 trials). Many other conditions were trialed in "Southeast Houston Research, Inc." in a lesser frequency.

Most popular intervention types in "Southeast Houston Research, Inc." are "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AKL-T01" (1 trials) and "Digital Treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southeast Houston Research, Inc." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Southeast Houston Research, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Southeast Houston Research, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southeast Houston Research, Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".